To determine whether HLA-B allotypes had an impact on clinical outcome, we performed univariate and multivariate Cox regression analyses of leukemia-free survival (LFS) for all alleles with an allele frequency of > 10% in the cohort. Here, HLA-B is linked to leukemia.